Aspect of Thrombolytic Therapy: A Review

Abstract EN

Thrombolytic therapy, also known as clot busting drug, is a breakthrough treatment which has saved untold lives.

It has been used in the clinical area to treat venous and arterial thromboembolic complaints which are a foremost cause of death.

In 1761, Morgagni lead the way of thrombolytic therapy.

Now day’s different types of thrombolytic drugs are currently available in market: alteplase, anistreplase, urokinase, streptokinase, tenecteplase, and so forth.

Thrombolytic therapy should be given with maintaining proper care in order to minimize the risk of clinically important bleeding as well as enhance the chances of successfully thrombolysis of clot.

These cares include preinfusion care, during the infusion care, and postinfusion care.

Besides proper knowledge of contraindication, evolutionary factor, and combination of drug is essential for successful thrombolytic therapy.

In these review we discussed about these aspect of thrombolytic therapy.